Cas:63857-00-1 N-[(3-(Anilinomethylene)-2-chloro-1-cyclohexen-1-yl)methylene]aniline monohydrochloride manufacturer & supplier

Chemical Name:N-[(3-(Anilinomethylene)-2-chloro-1-cyclohexen-1-yl)methylene]aniline monohydrochloride

CAS.NO:63857-00-1

Synonyms:L6Y BUTJ AU1MR& BG C1UNR &&HCl;N,N’-[(2-Chloro-1-cyclohexen-1-yl-3-ylidene)dimethylidyne]bis(benzenamine) hydrochloride;MFCD00191759;N-({2-Chloro-3-[(phenylimino)methyl]-2-cyclohexen-1-ylidene}methyl)aniline hydrochloride (1:1);N-({2-Chloro-3-[(phenylimino)methyl]cyclohex-2-en-1-ylidene}methyl)aniline hydrochloride;3-chloro-2,4-trimethylenenglutacondianil hydrochloride;4168817;Benzenamine, N,N’-[(2-chloro-1-cyclohexen-1-yl-3-ylidene)dimethylidyne]bis-, hydrochloride (1:1)

Molecular Formula:C₂₀H₂₀Cl₂N₂

Molecular Weight:359.292

HS Code:2925290090

Physical and Chemical Properties:

Melting point:224ºC (dec.)(lit.)

Boiling point:473.9ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:24.39000

Exact Mass:358.100342

LogP:6.93670

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like L6Y BUTJ AU1MR&amp chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenamine, N,N’-[(2-chloro-1-cyclohexen-1-yl-3-ylidene)dimethylidyne]bis-, hydrochloride (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,L6Y BUTJ AU1MR&amp Use and application,HCl technical grade,usp/ep/jp grade.

Related News: The Ballina facility was first established in 1974 and was acquired by Charles River in 2002. Over the years it has added to its capabilities offering a comprehensive package of GMP services in support of recombinant biologics, vaccines, cell and gene therapies, biosimilars, and medical devices. Charles River now employs 230 people at two facilities in Ireland: the site in Ballina Co. Mayo which focuses on biologics testing, and a site in Dublin, established in 2017, which serves as the EMEA and APAC headquarters for the Company’s Microbial Solutions division. DL-α-Methyl-β-(4-hydroxy-3-methyl-phenyl)-alanin manufacturers At least five million people worldwide have a form of lupus. No new treatments have been approved for SLE in over 10 years. 4-ethylamino-benzoic acid-(2-diethylamino-ethylamide) suppliers The license, granted by the Medicines and Healthcare Products Regulatory Agency (MHRA), allows Onyx to support API projects from pre-clinical studies to low volume commercial manufacture. N-(4-(9-((2,2,2-trifluoroethyl)carbamoyl)-9H-fluoren-9-yl)butyl)piperidine-4-carboxamide vendor & factory.